Peyronie's Disease: A Common Condition Men Don't Discuss

The Condition Hidden by Shame

Peyronie's disease (PD) is a fibrotic condition of the penis in which scar tissue (plaque) forms within the tunica albuginea — the tough connective tissue sheath surrounding the erectile bodies. The plaque causes penile curvature, shortening, pain, and erectile dysfunction. It affects an estimated 6-10% of men over age 40, according to a 2016 epidemiological study in Advances in Urology — making it far more common than most people realize.

Yet Peyronie's disease remains one of the least discussed conditions in men's health. A 2020 survey in The Journal of Sexual Medicine found that 73% of men with Peyronie's symptoms waited more than 12 months before seeking medical attention, with embarrassment and the belief that "nothing can be done" cited as the primary barriers. Both beliefs are misguided: the condition is medically legitimate, and effective treatments exist.

What Causes Peyronie's Disease

The Injury-Repair Hypothesis

The most widely accepted theory is that Peyronie's disease begins with micro-trauma to the tunica albuginea during sexual activity or physical injury. In most men, these micro-injuries heal normally. In men predisposed to PD, the healing process goes awry: instead of normal scar resolution, an aberrant wound healing response produces excessive collagen deposition and fibrotic plaque formation.

A 2017 review in Nature Reviews Urology described PD as a "localized fibroproliferative disorder" — essentially, the same type of dysfunctional wound healing seen in Dupuytren's contracture (fibrosis of the palm) and keloid scarring. In fact, 15-20% of men with Peyronie's also have Dupuytren's contracture, supporting a shared pathological mechanism.

Genetic Factors

Twin studies and family aggregation studies suggest a genetic component. A 2012 genome-wide association study in Human Molecular Genetics identified several loci associated with Peyronie's disease, many overlapping with genes involved in extracellular matrix regulation and wound healing. Men with a first-degree relative with PD have a 2-3x increased risk.

Associated Conditions

Several conditions increase PD risk:

Diabetes mellitus: 2-3x increased risk, likely due to microvascular damage and altered wound healing
Hypertension: Endothelial dysfunction may predispose to tunica injury
Dupuytren's contracture: 15-20% overlap
Age: Peak incidence in the 50s-60s, though cases in men in their 30s-40s are not uncommon
Radical prostatectomy: PD develops in 15-23% of men post-prostatectomy, per a 2011 study in BJU International

Natural History

Peyronie's disease progresses through two phases:

Acute Phase (6-18 months)

Active inflammation and plaque formation. During this phase:

Penile pain is common (particularly during erection)
Curvature may progress
Plaque may be palpable as a firm lump
Erectile function may decline

Stable/Chronic Phase (after 12-18 months)

Inflammation resolves, and plaque matures and calcifies. Pain typically resolves. Curvature stabilizes (neither improves nor worsens in most cases). Erectile dysfunction, if present, tends to persist.

A 2013 natural history study in The Journal of Urology following 246 men over 12 months found:

12% improved spontaneously
40% remained stable
48% worsened during the acute phase

Spontaneous resolution of significant curvature is uncommon, occurring in only 3-13% of cases in prospective studies.

Impact on Quality of Life

The psychological burden of Peyronie's disease is substantial and often underappreciated by clinicians. A 2018 study in The Journal of Sexual Medicine found that:

81% of men with PD reported significant emotional distress
48% met clinical thresholds for depression
54% reported relationship difficulties
75% reported decreased sexual frequency

The distress is not proportional to objective curvature severity — men with mild curvature often experience psychological distress comparable to those with severe deformity, because the perception of "abnormality" drives distress as much as functional impairment.

Treatment Options

Acute Phase Treatment

Intralesional collagenase (Xiaflex): The only FDA-approved drug for Peyronie's disease. Collagenase Clostridium histolyticum (CCH) is injected directly into the plaque, breaking down collagen and reducing curvature. The IMPRESS II trial, published in the Journal of Urology (2013), demonstrated a mean curvature improvement of 17 degrees (34% improvement) after 4 treatment cycles.

Traction therapy: External traction devices worn for 3-8 hours daily can restore penile length and reduce curvature. A 2019 systematic review in Translational Andrology and Urology found that traction therapy improved curvature by 10-30 degrees and penile length by 0.5-2.0 cm over 3-6 months. It is often used as an adjunct to other treatments.

Oral therapies: Pentoxifylline (an anti-fibrotic agent) is commonly prescribed off-label based on its mechanism of action, though a 2019 meta-analysis in Translational Andrology and Urology found limited evidence for clinically meaningful benefit. Vitamin E, potassium aminobenzoate, and tamoxifen have shown no significant efficacy in controlled trials.

Stable Phase Treatment

Observation: If curvature is mild (< 30 degrees), doesn't prevent intercourse, and isn't causing distress, monitoring is appropriate.

Surgical correction: For stable disease with curvature > 30-60 degrees causing functional impairment, surgery is the most effective treatment. Options include:

Plication (Nesbit/modified Nesbit): Shortening the longer side of the penis to straighten it. Simple, reliable, but causes 1-2 cm of penile shortening. Best for curvatures < 60 degrees with adequate penile length.
Plaque incision/excision with grafting: Cutting into or removing the plaque and patching with graft material (pericardium, dermis, or synthetic material). Preserves length but carries higher risk of new erectile dysfunction (10-20%).
Penile prosthesis: For men with PD and significant erectile dysfunction unresponsive to PDE5 inhibitors. An inflatable penile prosthesis corrects both the curvature and the ED simultaneously. A 2015 study in The Journal of Sexual Medicine reported satisfaction rates of 80-90% with prosthetic placement in PD patients.

What to Tell Your Doctor

If you notice penile curvature that's new, progressive, or associated with pain:

Seek evaluation early. Treatment during the acute phase (first 6-18 months) may prevent progression. Waiting until the stable phase limits options.
Request referral to a urologist — ideally one specializing in sexual medicine or reconstructive urology. General practitioners often lack training in PD management.
Describe the timeline. When did you first notice the curvature? Is it getting worse, stable, or better? Is there pain? These details determine the disease phase and guide treatment selection.
Discuss the psychological impact. Don't minimize the emotional burden. Depression and relationship strain are legitimate components of the condition that may benefit from concurrent treatment.

Peyronie's disease is not rare, not a sign of anything you did wrong, and not untreatable. The combination of collagenase injections, traction therapy, and — when needed — surgical correction can restore function and quality of life for the majority of affected men. The hardest part is the first conversation with a doctor. After that, the path forward is well-mapped.